Literature DB >> 11709348

Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model.

D M Barratt1, K Van Meter, P Asmar, T Nolan, C Trahan, L Garcia-Covarrubias, S E Metzinger.   

Abstract

Zygomycosis was induced by injecting CD-1 mice with 5 mg of intraperitoneal deferoxamine and then 10(6) CFU of intravenous and intrasinus Rhizopus arrhizus. The addition of hyperbaric oxygen (2.0 atm absolute twice daily) to amphotericin B did not improve survival over that achieved with amphotericin B and placebo air treatments.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709348      PMCID： PMC90877          DOI： 10.1128/AAC.45.12.3601-3602.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; T M Kerkering
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.

Authors:  F C Odds; F Van Gerven; A Espinel-Ingroff; M S Bartlett; M A Ghannoum; M V Lancaster; M A Pfaller; J H Rex; M G Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 3.  Oxygen and wound healing.

Authors:  F B LaVan; T K Hunt
Journal:  Clin Plast Surg       Date:  1990-07       Impact factor: 2.017

Review 4.  Intracranial complications of mucormycosis: an experimental model and clinical review.

Authors:  V K Anand; G Alemar; J A Griswold
Journal:  Laryngoscope       Date:  1992-06       Impact factor: 3.325

5.  Cerebral mucormycosis in diabetic mice after intrasinus challenge.

Authors:  A R Waldorf; R D Diamond
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

6.  Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.

Authors:  T M Gudewicz; J T Mader; C P Davis
Journal:  Aviat Space Environ Med       Date:  1987-07

7.  Amphotericin B-induced oxidative damage and killing of Candida albicans.

Authors:  M L Sokol-Anderson; J Brajtburg; G Medoff
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

8.  Patient survival factors in paranasal sinus mucormycosis.

Authors:  A Blitzer; W Lawson; B R Meyers; H F Biller
Journal:  Laryngoscope       Date:  1980-04       Impact factor: 3.325

9.  Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis.

Authors:  B J Ferguson; T G Mitchell; R Moon; E M Camporesi; J Farmer
Journal:  Rev Infect Dis       Date:  1988 May-Jun

Review 10.  Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.

Authors:  J R Boelaert; A Z Fenves; J W Coburn
Journal:  Am J Kidney Dis       Date:  1991-12       Impact factor: 8.860
View more
  7 in total

1.  Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.

Authors:  Elisabeth Maurer; Ulrike Binder; Manuela Sparber; Michaela Lackner; Rita Caramalho; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

Review 2.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.

Authors:  Sourabh Dhingra; Jay C Buckey; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 4.  Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective.

Authors:  Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

5.  Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure.

Authors:  N Ezra; K Dang; G Heuser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-27       Impact factor: 3.267

Review 6.  Therapy of Mucormycosis.

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Amalia Anastasopoulou; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2018-07-31

7.  A Rare Case of Pulmonary and Gastrointestinal Mucormycosis Due to Rhizopus spp. in a Child with Chronic Granulomatous Disease.

Authors:  Nnennaya U Opara
Journal:  Infect Dis Rep       Date:  2022-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.